Despite “a growing chorus of calls” for Canada to implement a single-payer, government-run prescription drug plan, researchers at the Fraser Institute have found that such a system may actually prove detrimental to low-income Canadians nationwide.
Despite “a growing chorus of calls” for Canada to implement a single-payer, government-run prescription drug plan, researchers at the Fraser Institute have found that such a system may actually prove detrimental to low-income Canadians nationwide.